<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Oncology</title>
            <link>https://medicalxpress.com/cancer-news/</link>
            <language>en-us</language> 
            <description>Latest medical news and research in Oncology</description>

                            <item>
                    <title>Celiac disease may raise risk of heart attack, stroke and early death</title>
                    <description>People with celiac disease and dermatitis herpetiformis have a slightly increased risk of cardiovascular disease, certain types of blood cancer, and premature death. This is shown by a large U.S. registry study led by researchers at Karolinska Institutet. The results are published in the journal The Lancet Regional Health—Americas.</description>
                    <link>https://medicalxpress.com/news/2026-05-celiac-disease-heart-early-death.html</link>
                    <category></category>
                    <pubDate>Fri, 29 May 2026 14:00:03 EDT</pubDate>
                    <guid isPermaLink="false">news699279721</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/doctor-listening-with.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>How lifestyle can protect childhood cancer survivors</title>
                    <description>Healthy lifestyles can reduce the risk of cardiovascular disease and other complications in childhood cancer survivors. These are the findings of two new international studies.</description>
                    <link>https://medicalxpress.com/news/2026-05-lifestyle-childhood-cancer-survivors.html</link>
                    <category></category>
                    <pubDate>Fri, 29 May 2026 13:40:06 EDT</pubDate>
                    <guid isPermaLink="false">news699279661</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/how-lifestyle-can-prot.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Targeted drug outperforms chemotherapy for patients with hard-to-treat lung cancer</title>
                    <description>The targeted therapy sunvozertinib was more effective than standard platinum-based chemotherapy as a first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) driven by EGFR exon 20 insertion mutations (EGFR exon20ins), according to new research from The University of Texas MD Anderson Cancer Center.</description>
                    <link>https://medicalxpress.com/news/2026-05-drug-outperforms-chemotherapy-patients-hard.html</link>
                    <category></category>
                    <pubDate>Fri, 29 May 2026 09:00:05 EDT</pubDate>
                    <guid isPermaLink="false">news699262944</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/lung.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>AI-powered atlas reveals new insights into tertiary lymphoid structures as prognostic and response biomarkers in cancer</title>
                    <description>In a study published in Science, researchers from The University of Texas MD Anderson Cancer Center have developed a spatial atlas of specialized immune structures, called tertiary lymphoid structures (TLSs), across multiple cancer types. This first-of-its-kind atlas revealed that TLS maturation state, spatial location and composition within tumors may provide clinically meaningful information about cancer prognosis and treatment response.</description>
                    <link>https://medicalxpress.com/news/2026-05-ai-powered-atlas-reveals-insights.html</link>
                    <category></category>
                    <pubDate>Thu, 28 May 2026 17:40:03 EDT</pubDate>
                    <guid isPermaLink="false">news699207601</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/ai-powered-atlas-revea.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Scientists identify metabolic target to overcome chemotherapy resistance in ovarian cancer</title>
                    <description>Many cancers can be treated by administering DNA-damaging agents, such as platinum-based chemotherapy, because the resulting DNA damage causes the cancer cells to die. A subset of cancers, however, including ovarian cancers, can repair their own DNA. Because such cancers survive despite chemotherapy, ovarian cancer patients whose tumors are DNA repair proficient have historically faced a poor prognosis and commonly recur within six months.</description>
                    <link>https://medicalxpress.com/news/2026-05-scientists-metabolic-chemotherapy-resistance-ovarian.html</link>
                    <category></category>
                    <pubDate>Thu, 28 May 2026 14:20:03 EDT</pubDate>
                    <guid isPermaLink="false">news699191699</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/wistar-institute-and-t.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Unexpected allies: Eosinophils may help predict cancer immunotherapy response and survival</title>
                    <description>Long regarded as cells involved primarily in allergic responses and antiparasitic defense, eosinophils are now drawing increasing attention in oncology. A review article led by Marie Gilon, an oncology resident physician and Ph.D. candidate at the University of Liège, synthesizes current knowledge on how these white blood cells interact with tumor biology and may inform the clinical management of cancer patients.</description>
                    <link>https://medicalxpress.com/news/2026-05-unexpected-allies-eosinophils-cancer-immunotherapy.html</link>
                    <category></category>
                    <pubDate>Thu, 28 May 2026 13:40:06 EDT</pubDate>
                    <guid isPermaLink="false">news699191101</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/eosinophils-and-cancer.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Veterans with cancer face years of elevated suicide risk, with danger highest just after diagnosis</title>
                    <description>Veterans diagnosed with cancer face a higher risk of suicide attempts—especially in the months following diagnosis—and that risk can persist for years, found a large, national study led by Oregon Health &amp; Science University and the Veterans Health Administration.</description>
                    <link>https://medicalxpress.com/news/2026-05-veterans-cancer-years-elevated-suicide.html</link>
                    <category></category>
                    <pubDate>Thu, 28 May 2026 11:00:06 EDT</pubDate>
                    <guid isPermaLink="false">news699093946</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/sad-man.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Breast tumors use sugar coating to evade immunity, opening potential immunotherapy path</title>
                    <description>Immunotherapies such as so-called checkpoint inhibitors activate the body&#039;s own immune system to fight cancer cells and have revolutionized the treatment of many types of tumor. In breast cancer, however, these therapies are often only of limited effectiveness. An international research team led by the Medical University of Vienna has now identified a previously underestimated mechanism by which breast tumors evade the immune system.</description>
                    <link>https://medicalxpress.com/news/2026-05-breast-tumors-sugar-coating-evade.html</link>
                    <category></category>
                    <pubDate>Wed, 27 May 2026 15:40:06 EDT</pubDate>
                    <guid isPermaLink="false">news699110102</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/breast-tumors-use-suga.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Lung cancer cells can revert identity to a branching state, fueling resistance and aggressive growth</title>
                    <description>Oncologists have discovered that lung cancer cells can change their identity to resist treatment. Research published in Molecular Oncology reveals how lung cancer cells can become more aggressive and harder to treat by reactivating a process involved in early lung development. The paper is titled &quot;Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma.&quot;</description>
                    <link>https://medicalxpress.com/news/2026-05-lung-cancer-cells-revert-identity.html</link>
                    <category></category>
                    <pubDate>Wed, 27 May 2026 13:40:01 EDT</pubDate>
                    <guid isPermaLink="false">news699100202</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/lung-cancer-cells-can.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Simple blood test could lead to personalized lung cancer treatment</title>
                    <description>A single blood test could help doctors predict how lung cancer patients will respond to treatment before therapy begins, researchers have found. University of Queensland-led research focused on non-small cell lung cancer (NSCLC), the most common form of the disease, and showed how analyzing proteins in a blood sample could support earlier and better-informed treatment decisions.</description>
                    <link>https://medicalxpress.com/news/2026-05-simple-blood-personalized-lung-cancer.html</link>
                    <category></category>
                    <pubDate>Wed, 27 May 2026 12:00:03 EDT</pubDate>
                    <guid isPermaLink="false">news699093555</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/simple-blood-test-coul.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Naturally occurring molecule may help outsmart melanoma</title>
                    <description>Melanoma is one of the deadliest forms of skin cancer, due in large part to its ability to rapidly develop resistance to treatment. Now, researchers at the University of California San Diego have identified a naturally occurring peptide—a small protein fragment composed of linked amino acids—that may help counter one of cancer&#039;s most dangerous survival strategies.</description>
                    <link>https://medicalxpress.com/news/2026-05-naturally-molecule-outsmart-melanoma.html</link>
                    <category></category>
                    <pubDate>Wed, 27 May 2026 10:40:02 EDT</pubDate>
                    <guid isPermaLink="false">news699093165</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/research-alert-natural.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Blocking two cancer pathways may curb medulloblastoma relapse, preclinical study suggests</title>
                    <description>For most children diagnosed with medulloblastoma, the most common malignant pediatric brain tumor, survival rates are encouraging. But for a subset, remission is not the end of the story. Roughly 30% of patients will see their cancer return, and once it does, outcomes are often devastating.</description>
                    <link>https://medicalxpress.com/news/2026-05-blocking-cancer-pathways-curb-medulloblastoma.html</link>
                    <category></category>
                    <pubDate>Tue, 26 May 2026 16:00:06 EDT</pubDate>
                    <guid isPermaLink="false">news699029432</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/targeting-tumor-relaps.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Vitamin D analog shuts down pancreatic cancer&#039;s shield in a clinical trial</title>
                    <description>A small clinical trial led by Dana-Farber Cancer Institute researchers has put a Salk Institute idea to the test in patients: that activating the vitamin D receptor can help reshape the protective environment surrounding pancreatic tumors in ways that could make the notoriously difficult-to-treat cancer more vulnerable to therapeutic treatments.</description>
                    <link>https://medicalxpress.com/news/2026-05-vitamin-d-analog-pancreatic-cancer.html</link>
                    <category></category>
                    <pubDate>Tue, 26 May 2026 15:52:42 EDT</pubDate>
                    <guid isPermaLink="false">news699029406</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/from-salk-institute-di.jpg" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
